Asian Spectator

Men's Weekly

.

RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
TEL AVIV, Israel and RALEIGH, N.C., November 20, 2020, /PRNewswire-AsiaNet/-- RHB-204 is being evaluated as a first-line, stand-alone, oral treatment for pulmonary nontuberculous mycobacteria (NTM) disease - a rare condition with no FDA-approved first-line therapyThe Phase 3 study is expected to recruit up to 125 patien...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Legal Mistakes to Avoid When Buying a Business

Purchasing an existing business can be an exciting step. However, buying a business comes with a web of legal complexities that can quickly turn a dream investment into a nightmare if not handled co...

Jangan mati di kota besar: Akses sulit, biaya pun mahal

Pemakaman umum di tengah kota Jakarta yang sepi dan cuaca mulai mendung.hanya_rafli/Shutterstock● Tingginya biaya proses pemakaman di kota besar menjadi beban bagi warga kelas menengah ke bawah...

Demonstrasi massa di Pati: Tanda suara rakyat tak pernah mati

Keputusan Bupati Pati, Sudewo, untuk menaikkan tarif Pajak Bumi dan Bangunan Perdesaan dan Perkotaan (PBB-P2) memicu gelombang penolakan dari masyarakat. Puncaknya, pada 13 Agustus 2025, ribuan warga ...